Eli Lilly and Co., of Indianapolis, initiated an exchange offer to divest its remaining interest in Elanco Animal Health Inc., of Greenfield, Ind. Elanco completed its IPO in September 2018, with Lilly retaining an 80.2 percent ownership interest in Elanco.